Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2005
07/21/2005US20050160500 Recombinant seeds for propagating drought and freeze resistant crops; early flowering
07/21/2005US20050160499 Vernalization-related molecules and methods for inducibly-conferring epigenetic changes
07/21/2005US20050160498 Controlling flowering in plants via gene expression inhibition of cysteine proteases
07/21/2005US20050160497 Protein which has an activity to produce raffinose from sucrose and galactinol
07/21/2005US20050160496 Using vector transformation tand plastid transit peptides to reducing starch granule size; increasing digestibility of plant grain or forage
07/21/2005US20050160494 Alteration of oil traits in plants
07/21/2005US20050160493 Yield-related polynucleotides and polypeptides in plants
07/21/2005US20050160492 Proteinase or methyltransferase inhibitors; enzyme inhibitors; treatment and prevention of pathogen infection; biological pest control
07/21/2005US20050160491 Transgenic plants compromising nucleic acid molecules encoding RAR1 disease resistance proteins and uses thereof
07/21/2005US20050160490 Transgenic nematode expressing integration host factors (IHFs); bioreactor for heterologous gene expression[; antisense agents; gene transfer and propagation tool
07/21/2005US20050160489 Geranylgeranyl pyrophosphate synthases
07/21/2005US20050160488 Grain quality through altered expression of seed proteins
07/21/2005US20050160487 Having a lesser leaf angle compared to the leaf angle of inbred maize line A619 and when crossed with other inbred maize lines produce hybrids having excellent root lodging.
07/21/2005US20050160485 Mouse in which genome is modified
07/21/2005US20050160483 Glycosaminoglycan deficient proteoglycan expressed in recombinant goat; antiscarring agents and reconstructive/cosmetic surgery
07/21/2005US20050159898 Method that aligns cDNA sequences to genome sequences
07/21/2005US20050159589 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor
07/21/2005US20050159386 Antitumoral composition based on immunogenic polypeptide with modified cell location
07/21/2005US20050159384 Human RNase III and compositions and uses thereof
07/21/2005US20050159382 For cancer such as prostate cancer
07/21/2005US20050159381 Cancer, tumor angiogenesis, diabetic retinopathy, inflammatory conditions such as arthritis, osteoporosis, wound healing
07/21/2005US20050159380 used to modulate the expression of Angiopoietin genes
07/21/2005US20050159379 RNA interference mediated inhibition of gastric inhibitory polypeptide (GIP) and gastric inhibitory polypeptide receptor (GIPR) gene expression using short interfering nucleic acid (siNA)
07/21/2005US20050159378 For proliferative diseases and disorders such as multiple drug resistant cancers, such as leukemias including acute myelogenous leukemia (AML), chronic myelogenous leukemia (CML), Acute lymphocytic leukemia (ALL) , lymphoma, prostate cancer, carcinoma
07/21/2005US20050159377 Methods of modulating activity of prokaryotic ribosomes
07/21/2005US20050159376 RNA interference mediated inhibition 5-alpha reductase and androgen receptor gene expression using short interfering nucleic acid (siNA)
07/21/2005US20050159374 Gene expression inhibition; for treatment of tumors, cancer
07/21/2005US20050159373 Novel polypeptides, and nucleic acids encoding the same
07/21/2005US20050159355 For treatment of inflammatory diseases
07/21/2005US20050159350 Has superagonist properties and is used to stimulate cell division and treat wounds, ischemia, heart disease, neural injuries, peripheral vascular disease, gastric ulcers and duodenal ulcers
07/21/2005US20050159349 For treatment of cancer; nontoxic
07/21/2005US20050159348 Methods of treatment of periodontal disease
07/21/2005US20050159333 Carbachol, neurokinin A, P2X receptor antagonist, electrical stimulus, to inhibit polypeptide in Rho associated kinase pathway; lower urinary tract disorders, overactive bladder
07/21/2005US20050159332 Ntb-a,a a surface molecule involved in natural killer cellss activity
07/21/2005US20050158861 Yeast transformation vector containing auxotrophic dominant gene yeast transfomant containing it and their preparation
07/21/2005US20050158860 Method for evolving a cell having desired phenotype and evolved cells
07/21/2005US20050158855 Use of TGF beta superfamily antagonists to make dopaminergic neurons from embryonic stem cells
07/21/2005US20050158844 Methods for eliminating or reducing the expression of a genes in a filamentous fungal strains
07/21/2005US20050158843 Non-sporulating bacillus subtilis having parts of the gene encoding sigma g deleted
07/21/2005US20050158842 Microorganisms and assays for the identification of antibiotics
07/21/2005US20050158838 Novel enterokinase cleavage sequences
07/21/2005US20050158836 Transgenic microorganism comprising gene sequences coding alcohol dehydrogenase and pyruvate decarboxylase for use as bioreactor for fermentation of ethanol
07/21/2005US20050158834 Using site directed mutagenesis in transgenic microorganism to generate single-stranded nicking enzyme
07/21/2005US20050158833 Using enhanced green fluorescent protein as reporter molecule in studying cell lineages
07/21/2005US20050158832 Secreted glycoprotein hormone fusion for use in regulating the level of red blood cells in circulation
07/21/2005US20050158828 Preparing immunoglobulin dimer for use in prevention and treatment of B cell lymphoma and chronic lymphocytic leukemia; immunotherapeutics
07/21/2005US20050158826 Using tumor necrosis factor receptor releasing enzyme as therapeutic tool in treatment of inflammation, arthritis, rheumatoid arthritis and multiple sclerosis
07/21/2005US20050158824 Using chinese hamster ovaries as bioreactor for production of nerve growth factor for use in prevention and treatment of nervous system disorders
07/21/2005US20050158823 Using tumor necrosis factor related apoptosis inducing ligand (TRAIL) as tool in tissue targeted treatment of cancer cells
07/21/2005US20050158821 Methods for the purification and aqueous fiber spinning of spider silks and other structural proteins
07/21/2005US20050158820 In vivo production of cyclic peptides
07/21/2005US20050158818 Recombinant hydrolase for use in the preparation of 7-amino-cephalosporanic acid; bioreactors
07/21/2005US20050158816 Using yeast model comprising aequorin reporter as tool in screening compound toxicity; bioassay and drug screening
07/21/2005US20050158810 Diagnostic method for cancer characterized in the detection of the deletion of G-CSF exon 3
07/21/2005US20050158807 Tumour markers and biological applications thereof
07/21/2005US20050158803 binding antibody to substrate; neutralization of infection prions; in vivo diagnosis testing
07/21/2005US20050158800 Detecting the expression of a G-protein coupled receptor, identifying agonists or antagonists of the receptor
07/21/2005US20050158796 Use of a tag to enrich polypeptides libraries
07/21/2005US20050158794 Luminescent markers
07/21/2005US20050158789 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
07/21/2005US20050158788 Methods, software and apparati for identifying genomic regions harboring a gene associated with a detectable trait
07/21/2005US20050158785 Non-peptide compounds 2-(5(6)-nitro-2-benzimidazoyl)-5-(4-nitrophenyl)furan; for use in bioassay, fluorescent quantitative analysis; control of gene expression, treatment/prevention of cancer
07/21/2005US20050158784 Nucleic acids of the human ABCC11 gene, vectors containing such nucleic acids and uses thereof
07/21/2005US20050158783 Reagent for the isolation of RNA
07/21/2005US20050158782 Magnetic fine particles having lower critical solution temperature
07/21/2005US20050158780 Nucleic acid ligands to the prostate specific membrane antigen
07/21/2005US20050158779 Tumor antigen probes for detection of cell proliferative disorders
07/21/2005US20050158778 Transcription factor for use in generating immoglobulin for prevention and treatment of fungal infection
07/21/2005US20050158777 Nucleotide sequences-carbon nanotube composite for separarting and identifying pererential nucleotides; gene expression analysis
07/21/2005US20050158774 Expression vector comprising plant seed coat promoter for use as tool in enhancement of transcription of heterologous gene expression sequences; bioreactors
07/21/2005US20050158771 Using gene expression patterns and skeletal muscle marker as diagnostic tool in detection and prognostication of obesity
07/21/2005US20050158769 Using vector transformed cell as bioreactor vehicle for heterologous gene expression; directed protein evolution
07/21/2005US20050158766 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
07/21/2005US20050158765 Solid phase synthesis
07/21/2005US20050158764 Alternatively spliced juvenile hormone receptor genes for use in identifying modulators for insect propagation; biological pest control
07/21/2005US20050158762 Novel 2,5-diketo-L-gluconic acid reductases and methods of use
07/21/2005US20050158761 Method for sequencing nucleic acid molecules
07/21/2005US20050158758 Using short anti-sense RNA sequences to treat and prevent cell proliferative and viral diseases
07/21/2005US20050158753 Using presence of gastrointestinal system protein (CS141) as diagnostic indcator of gastrointestinal disorders; diagnosing colon and rectum cancer
07/21/2005US20050158752 amplifying a region of the nucleic acid in a solution of nucleic acid acting as a template, a pair of primers, deoxynucleotides, and dideoxynucleotides, hybridizing amplified products to a probe anddetecting the hybridization between the amplified products and the probe
07/21/2005US20050158750 Expression vector comprising nucleotide sequences coding interleukin specific immunoglobulin for use in regulating activation, development, differentiation and function of hematopoietic cells
07/21/2005US20050158749 Avermectin aglycon synthase genes
07/21/2005US20050158746 Expression monitoring by hybridization to high density oligonucleotide arrays
07/21/2005US20050158744 Microarray comprising preferential oligonucleotides for use in drug screening and disease diagnosis
07/21/2005US20050158741 Self-cleaving ribozymes and uses thereof
07/21/2005US20050158735 Double stranded RNA sequences for use in prevention and treatment of restenosis and cell proliferative disorders; gene expression inhibition
07/21/2005US20050158731 Preparing polynucleotide or oligonucleotide probes specific for use in detection of neuroectodermal tumors of childhood, breast, colon, head, neck and testiclular cancer
07/21/2005US20050158730 Compositions and methods utilizing DNA polymerases
07/21/2005US20050158726 Compositons and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene
07/21/2005US20050158724 Methods, of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
07/21/2005US20050158722 Nucleic acid quantification
07/21/2005US20050158721 Using overexpression of senescence-associated genes as diagnostic/prognostic indicator of organ rejection/failure
07/21/2005US20050158719 Polypeptide serving as angiogenic marker and dna thereof
07/21/2005US20050158716 Nucleic acid detection kits
07/21/2005US20050158714 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
07/21/2005US20050158711 viral vector containing a polynucleotide sequence contains two different affinity tag sequences, one of the two affinity tag sequences encodes streptavidin-binding peptide and other encodes calmodulin binding peptide
07/21/2005US20050158710 Oligonucleotide primers and/or hybridization probes for use as diagnostic tools in detecting picornavirus infection; diagnosing gastrointestinal disorders
07/21/2005US20050158707 Full - length genomic RNA of papaya leaf - distortion mosaic virus
07/21/2005US20050158705 Gene screening method using nuclear receptor
07/21/2005US20050158608 Method for manufacturing a layer lamination integrated fuel cell and the fuel cell itself